Basit öğe kaydını göster

dc.contributor.authorBireller, Elif S.
dc.contributor.authorCakmakoglu, Bedia
dc.contributor.authorURE, Oznur Sari
dc.contributor.authorRencuzogullari, Cagla
dc.contributor.authorVELET, Mustafa
dc.contributor.authorAKTUGLU, Mehmet Burak
dc.contributor.authorAYER, Mesut
dc.contributor.authorACIK, Hasan
dc.contributor.authorKARAALI, Zeynep
dc.contributor.authorALIOGLU, Taner
dc.contributor.authorYIGIT, Namik
dc.contributor.authorAtalay, Eray
dc.date.accessioned2021-03-03T21:14:13Z
dc.date.available2021-03-03T21:14:13Z
dc.date.issued2014
dc.identifier.citationAKTUGLU M. B. , AYER M., Bireller E. S. , Rencuzogullari C., ACIK H., KARAALI Z., ALIOGLU T., YIGIT N., VELET M., Atalay E., et al., "Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population", MEDICAL ONCOLOGY, cilt.31, sa.10, 2014
dc.identifier.issn1357-0560
dc.identifier.othervv_1032021
dc.identifier.otherav_5e1bc737-dae3-47f8-9b15-f1986718591f
dc.identifier.urihttp://hdl.handle.net/20.500.12627/65823
dc.identifier.urihttps://doi.org/10.1007/s12032-014-0174-6
dc.description.abstractThe aim of this study was to assess the possible influence of genetic polymorphisms in hOGG1, XRCC1, XRCC3, XPD, XPG and APE1 on the observed DNA damage in a group of Turkish myelodysplastic syndrome (MDS) patients. A total of 39 patients with myelodysplastic syndrome and 78 age-matched healthy control subjects were included in our study. Polymerase chain reaction/restriction fragment length polymorphism analysis was performed for the detection of DNA repair gene variants. No significant differences in DNA repair enzymes APE1, XRCC1 and XPG were found between MDS patients and controls. On the other hand, XRCC3, XPD and hOGG1 were associated with an increased risk of MDS (p = 0.004, p = 0.000, p = 0.017, respectively). Specifically, Thr/Met genotype was more relevant in patients (p = 0.026) in XRCC3; in hOGG1, Cys+ genotype was found higher in patients (p = 0.017); and in XPD, Gln/Gln genotypes were found higher in the patient (p = 0.001). In conclusion, XRCC3, XPD and hOGG1 genotypes are associated with an increased MDS risk, suggesting their possible involvement in the pathogenesis and biology of this disease.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleInvestigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population
dc.typeMakale
dc.relation.journalMEDICAL ONCOLOGY
dc.contributor.departmentSağlık Bilimleri Üniversitesi , ,
dc.identifier.volume31
dc.identifier.issue10
dc.contributor.firstauthorID69395


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster